DOI: 10.12890/2025_005866

Raynaud’s phenomenon and pericardial effusion requiring management with a pericardial window as the only manifestations of systemic sclerosis without scleroderma for over 10 years, after which pulmonary hypertension developed

Authors

  • Natassja Moriarty Rheumatology, Broadgreen Hospital, Liverpool, United Kingdom 0000-0001-8967-3436
  • Thivya Dharshini V. Vadiveloo Rheumatology, Broadgreen Hospital, Liverpool, United Kingdom
  • Fathelrahman Osman Rheumatology, Broadgreen Hospital, Liverpool, United Kingdom
  • Rosalind Benson Rheumatology, Aintree University Hospital, Liverpool, United Kingdom
  • Katherine Nelson Rheumatology, Broadgreen Hospital, Liverpool, United Kingdom

simplysanaja@gmail.com

Keywords

Systemic sclerosis, systemic sclerosis sine scleroderma, pericardial effusion, pulmonary hypertension

Abstract

Introduction: Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterised by vasculopathy and progressive fibrosis affecting the skin and internal organs. Systemic sclerosis sine scleroderma (ssSSc) is an uncommon variant, accounting for 5–10% of cases and is defined by the absence of cutaneous involvement despite internal organ manifestations.
Case description: We present a case of a patient who initially presented with recurrent pericardial effusion and late-onset Raynaud’s phenomenon. Despite serological markers, SSc was not diagnosed, due to absence of skin involvement, until pulmonary hypertension (PH) developed over a decade later. Nailfold capillaroscopy confirmed ssSSc. Surgical pericardial drainage and targeted PH therapy led to clinical improvement.
Discussion: Pericardial effusion may be an early and under-recognised manifestation of ssSSc. While typically attributed to inflammation, our patient had a transudative effusion with a poor response to steroids, suggesting a non-inflammatory mechanism. The effusion preceded PH by over a decade, challenging current pathophysiological theories. Surgical drainage was effective, contrasting with poorer outcomes in cutaneous SSc.
Conclusion: This case highlights the diagnostic complexity and heterogeneity of cardiac involvement in ssSSc. It underscores the importance of maintaining a high index of suspicion in patients with unexplained cardiopulmonary symptoms and demonstrates the indolent course of the disease in atypical SSc.

View the entire article

Downloads

References

  1. Lescoat A, Huang S, Carreira PE, Siegert E, Jeska de Vries-Bouwstra E, Distler W, et al. Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma. JAMA Dermatol 2023;159:837-842. doi: 10.1001/jamadermatol.2023.1729
  2. Chilukuri B, Chinnadurai S, Mahendran B, Ramamoorthy R, Selvakumar B, Sankaralingam R. Systemic sclerosis sine scleroderma: characteristics of a south Indian cohort from a tertiary care centre. Ann Rheum Dis 2018;77:1506.3-1507.
  3. Kucharz E, Kopec-Medrek M. Systemic sclerosis sine scleroderma. Adv Clin Exp Med 2017;26:875-880. doi: 10.17219/acem/64334
  4. Toya SP, Tzelepis GE. The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications. Rheumatol Int 2009;29:861-868. doi: 10.1007/s00296-009-0878-7
  5. Itolikar SM, Salagre S, Phatak S, Itolikar M. Recurrent cardiac tamponade in a young woman. BMJ Case Rep 2013;2013:bcr2013201472. doi: 10.1136/bcr-2013-201472
  6. Perez-Bocanegra C, Fonollosa V, Simeon CP, Candell J, Solans R, Gomez A, et al. Pericardial tamponade preceding cutaneous involvement in systemic sclerosis. Ann Rheum Dis 1995;54:687-688. doi: 10.1136/ard.54.8.687-b
  7. Kitchongcharoenying P, Foocharoen C, Mahakkanukrauh A, Suwannaroj S, Nanagara R. Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients. Asian Pac J Allergy Immunol 2013;31:314-319. doi: 10.12932/AP0305.31.4.2013
  8. Fernández Morales A, Iniesta N, Fernández-Codina A, Vaz de Cunha J, Pérez Romero T, Hurtado García R, et al. Cardiac tamponade and severe pericardial effusion in systemic sclerosis: report of nine patients and review of the literature. Int J Rheum Dis 2017;20:1582-1592. doi: 10.1111/1756-185X.12952
  9. Dunne JV, Chou JP, Viswanathan M, Wilcox P, Huang SH. Cardiac tamponade and large pericardial effusions in systemic sclerosis: a report of four cases and a review of the literature. Clin Rheumatol 2011;30:433-438. doi: 10.1007/s10067-010-1667-0
  10. Yee BL, Varada NL, Rahimi OM, Palma CF, Al-Taweel OS, Ahsan CH. Scleroderma as an Uncommon Cause of Pericardial Effusion. Kans J Med 2022;15:257-258. doi: 10.17161/kjm.vol15.17026
  11. Fischer A, Misumi S, Curran-Everett D, Meehan RT, Ulrich SK, Swigris JJ, et al. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease. Chest 2007;131:988-992. doi: 10.1378/chest.06-2317

Published

2025-10-28

How to Cite

1.
Moriarty N, Vadiveloo TDV, Osman F, Benson R, Nelson K. Raynaud’s phenomenon and pericardial effusion requiring management with a pericardial window as the only manifestations of systemic sclerosis without scleroderma for over 10 years, after which pulmonary hypertension developed. EJCRIM [Internet]. 2025 Oct. 28 [cited 2026 Nov. 3];12(11). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5866

Most read articles by the same author(s)